Big Pharma Infographic: The Stats About Pharmaceutical Companies

| March 2, 2017

article image
In the spirit of “know your enemy”, here is a great Big Pharma infographic titled: The Stats About Pharmaceutical Companies, from My[confined]Space. Americans know that we’re paying too much for our healthcare, we’re just not sure how it is happening to us. This infographic gives you a little taste of the excesses in prescription pharmaceutical business, Big Pharma, both in financial profits and massive spending on marketing. Make no mistake, cannabis or medical marijuana that you can grow in your back yard or closet, is no friend of the pharmaceutical industry.

Spotlight

Akira

Akira is reimagining Canadian healthcare we're changing how healthcare is delivered and empowering patients to be engaged and proactive about their health. Right Health combines virtual and face-to-face care to offer on-demand, accessible healthcare convenience at your fingertips. Akira is the technology platform within Right Health’s offering that provides you with an instant connection to great Canadian doctors, nurse practitioners, and more all by secure text or video through the Akira smartphone app.

OTHER ARTICLES

The Future of Pharma Beyond Blockbusters

Article | March 17, 2020

We’ve all heard the saying “treat the patient, not the disease”, and this couldn’t be truer in today’s ever-changing pharmaceutical landscape. We are living in a time of revolution – advancements in genomics and technology are improving our ability to develop precise drugs and targeted therapies, rather than focusing on a one size fits all approach. Each individual’s genetic makeup is slightly different from everyone else’s,

Read More

Coronavirus Pandemic Brings Hundreds Of U.S. Clinical Trials To A Halt

Article | April 11, 2020

Rene Roach fired off a quick email in late March for an update on a colorectal cancer clinical trial for which she hoped to qualify. Worried about the coronavirus, she asked, almost as an afterthought, whether the study had been put on hold because of the pandemic.The answer crushed her: It had been. "That's when COVID-19 shut down everything," says Roach, 50, of Germantown, Md. Roach assumed that there would be workarounds for patients like her, who have stage IV cancer. These patients often depend on clinical trials as their best chance to knock cancer out when other therapies have failed. For now, she's being treated with traditional chemotherapy, but she was counting on the drug cocktail from the clinical trial. She figures if chemo was going to rid her body of cancer for good, it would have done so already.

Read More

How pharma can continue engaging HCPs in a world gripped by COVID-19

Article | April 10, 2020

Medscape is the leading source of clinical news, health information, and point-of-care tools for healthcare professionals. Medscape offers specialists, primary care physicians, and other health professionals the most robust and integrated medical information and educational tools. Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses and other educational programmes for physicians, nurses, and other healthcare professionals. Both Medscape and Medscape Education are part of WebMD Health Corp., an Internet Brands company. Face-to-face interactions between pharma and physicians have essentially ceased overnight during the COVID-19 pandemic, but that doesn’t mean HCPs have stopped looking for new medical information.

Read More

3 Big Pharma Stocks Plunging the Most During the Coronavirus Stock Market Crash: Are They Buys?

Article | March 26, 2020

Big pharma stocks have been clobbered during the coronavirus-caused stock market crash. You can count the number of drugmakers with market caps of $25 billion or more whose shares haven't dropped by double-digit percentages on one hand -- and have several fingers left over. Three big pharma stocks have plunged the most: AbbVie (NYSE:ABBV), Bristol Myers Squibb (NYSE:BMY), and Pfizer (NYSE:PFE). But are these stocks smart picks to buy right now?

Read More

Spotlight

Akira

Akira is reimagining Canadian healthcare we're changing how healthcare is delivered and empowering patients to be engaged and proactive about their health. Right Health combines virtual and face-to-face care to offer on-demand, accessible healthcare convenience at your fingertips. Akira is the technology platform within Right Health’s offering that provides you with an instant connection to great Canadian doctors, nurse practitioners, and more all by secure text or video through the Akira smartphone app.

Events